22h
Zacks.com on MSNVertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to KnowVertex Pharmaceuticals (VRTX) reachead $495.29 at the closing of the latest trading day, reflecting a +1.42% change compared to its last close.
4h
Zacks.com on MSNGILD vs. VRTX: Which Stock Is the Better Value Option?But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. The best way to find great value stocks is to pair a strong Zacks Rank with an ...
For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study.
‘The hangover can last longer than the party’: Biotech is in a major slump, with no end in sight
There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.
In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.
Sensus Healthcare (NASDAQ:SRTS – Get Free Report) had its price objective cut by equities research analysts at Lake Street Capital from $18.00 to $13.00 in a report issued on Tuesday,Benzinga reports.
March 12, 2025 · 4 min read Clement Farabet, VP of Research at Google DeepMind (GOOGL), and Tris Warkentin, Director at Google DeepMind, unveiled Gemma 3 today—a groundbreaking leap in lightweight, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results